VR Logo

MyMD Pharmaceuticals Inc. (MYMD) download report


Healthcare | Biotechnology & Pharma Research

MyMD Pharmaceuticals Inc. (MYMD) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease.

IPO Date: 23-Jan-2014

Pres, Chief Medical Officer & Director: Dr. Christopher C. Chapman Jr., M.D.

Exec. VP of Operations & Gen. Counsel: Mr. Paul Rivard Esq.

Listing: NASDAQ: MYMD

Country: United States

Headquarters: Baltimore, MD

Website: https://www.mymd.com

Key Facts

Market cap: $76.12 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-30.92 Mln

Cash: $9.19 Mln

Total Debt: $0.13 Mln

Insider's Holding: 10.80%

Liquidity: Low

52 Week range: $1.88 - 9.95

Shares outstanding: 38,058,200

10 Years Aggregate:

  • CFO: $-65.07 Mln
  • EBITDA: $-28,862.45 Mln
  • Net Profit: $-29,946.89 Mln

Stock Performance

Time Period MyMD Pharmaceuticals (MYMD) S&P BSE Sensex S&P Small-Cap 600
YTD-61.39-9.18-18.78
1 month-21.48-4.78-8.00
3 months-49.79-9.66-13.65
1 Year-62.860.81-17.19
3 Years-52.3310.336.10
5 Years-65.5211.345.87
10 Years--11.749.84
As on 01-Jul-2022
Year MyMD Pharmaceuticals (MYMD) S&P Small-Cap 600 S&P BSE Sensex
202152.2625.2721.99
2020-37.819.5715.75
2019-88.2020.8614.38
20185.38-9.705.87
2017-92.9511.7327.91
201657.0224.741.95
2015-69.67-3.36-5.03